378 results on '"Hettmer, Simone"'
Search Results
2. Controlled flow reduction of an iliacoportal shunt graft for portal vein arterialization in a pediatric patient
3. Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
4. Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
5. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis
6. Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry
7. Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
8. Epidemiology of Bone and Soft Tissue Sarcomas
9. The AYA gap for rhabdomyosarcoma
10. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group
11. Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
12. Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen
13. Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography.
14. Community-driven development of a modified progression-free survival ratio for precision oncology
15. Case Report: Lomustine overdose in a 15-year-old, healthy adolescent--a prescription failure.
16. Epidemiology of Bone and Soft Tissue Sarcomas
17. Comments About Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas
18. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
19. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas
20. Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
21. Supplementary Table from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
22. Supplementary Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
23. Supplementary Table S3 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
24. Data from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
25. Supplementary Figure from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
26. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
27. Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)
28. Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
29. Rhabdomyosarcoma xenotransplants in zebrafish embryos
30. Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)
31. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
32. Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma
33. Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
34. Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
35. ATRT-09. Outcome and therapeutic interventions in relapsed and refractory ATRT – The EU-RHAB perspective
36. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
37. Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
38. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells
39. Additional file 1 of Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
40. Lack of Electron Acceptors Contributes to Redox Stress and Growth Arrest in Asparagine-Starved Sarcoma Cells
41. Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
42. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
43. Hedgehog-driven myogenic tumors recapitulate skeletal muscle cellular heterogeneity
44. Rhabdomyosarcoma xenotransplants in zebrafish embryos.
45. Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study
46. The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
47. Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors
48. The landscape of genomic alterations across childhood cancers
49. Author Correction: The landscape of genomic alterations across childhood cancers
50. A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.